Celltrion to merge with Celltrion Healthcare, Celltrion Pharm in 2 phases
Seo Jung-jin, chairman of Celltrion Group, speaks during an online press conference, Thursday. Captured from conferenceBy Baek Byung-yeulCelltrion, a biosimilar producer, will merge with Celltrion Healthcare, a group subsidiary responsible for marketing biosimilar and other medicines, this year to create business synergy, Celltrion Group Chairman Seo Jung-jin said Thursday. He also said that the merged unit will later absorb Celltrion Pharm, the group's chemical pharmaceuticals maker.The term biosimilar means a biologic medical product that is almost an identical copy of an original product that is manufactured by a different company."Celltrion is expected to complete the merger of Celltrion Healthcare by the end of the year, followed by the next merger with Celltrion Pharm in the next six months,” the chairman said during an online conference.Seo holds a 95 percent stake in Celltrion Holdings, which has a 20.02 percent stake in Celltrion and a 35.54 percent stake in Celltrion Healthcare, respectively. Celltrion has a 54.96 percent stake in Celltrion Pharm.Celltrion announced i
